Our aim is to be recognised as a research-focused Company, able to develop and commercialize innovative pharmaceutical solutions to improve the quality of human life.

Noventia Pharma  is committed to the research and development of new drug entities within the Dermatology, Gynecology and  for ENT Specialists as well as for for Orphan Drugs for the treatments of  Rare Diseases and more in particular in CNS (Wilson Disease patients)

Another important area of development is the development of novel diagnostics, vaccines, and therapeutic products that improve the therapeutic approaches to treat infectious diseases throughout the developing world .

The main focus is today on eradicating tuberculosis, leishmaniasis, leprosy, malaria, and Chagas Disease .